T1	Participants 224 268	recruited 205 patients from 16 investigators
T2	Participants 315 339	patients were randomized
T3	Participants 644 656	three groups
T4	Participants 759 771	trandolapril
T5	Participants 798 802	HCTZ
T6	Participants 965 982	combination group
T7	Participants 1179 1192	three groups.
T8	Participants 1276 1281	HCTZ.
